![]() |
Alzheimer's Disease |
Free Subscription
1 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
The interactome of tau phosphorylated at T217 in Alzheimer's disease human brain
tissue.
Acta Neuropathol. 2025;149:44.
PubMed
Abstract available
Targeted proteomic biomarker profiling using NULISA in a cohort enriched with
risk for Alzheimer's disease and related dementias.
Alzheimers Dement. 2025;21:e70166.
PubMed
Abstract available
Astrocytes, via RTP801, contribute to cognitive decline by disrupting
GABAergic-regulated connectivity and driving neuroinflammation in an Alzheimer's
disease mouse model.
Alzheimers Dement. 2025;21:e70051.
PubMed
Abstract available
Hyperactivation of RAB5 disrupts the endosomal Rab cascade leading to
endolysosomal dysregulation in Down syndrome: A necessary role for increased APP
gene dose.
Alzheimers Dement. 2025;21:e70046.
PubMed
Abstract available
Antisense oligonucleotides directed against App and Rab5 normalized endosomal Rab
activity and reversed DS-AD-linked degenerative phenotypes in the Dp16 mouse
model of Down syndrome.
Alzheimers Dement. 2025;21:e70022.
PubMed
Abstract available
Aquaporin 4 modulation drives amyloid burden and cognitive abilities in an APPPS1
mouse model of Alzheimer's disease.
Alzheimers Dement. 2025;21:e70164.
PubMed
Abstract available
Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and
design for a 12-month randomized trial.
Alzheimers Dement. 2025;21:e70219.
PubMed
Abstract available
Plasma biomarkers as core mediators in functional network abnormalities: Evidence
from a two-cohort study.
Alzheimers Dement. 2025;21:e70114.
PubMed
Abstract available
Am J Alzheimers Dis Other Demen
Predicting and Evaluating Cognitive Status in Aging Populations Using Decision
Tree Models.
Am J Alzheimers Dis Other Demen. 2025;40:15333175251339730.
PubMed
Abstract available
Network Analysis of Delusion Subtypes in Amyloid PET-Positive, Drug-Naive
Alzheimer's Disease Patients.
Am J Geriatr Psychiatry. 2025 Apr 22:S1064-7481(25)00329.
PubMed
Abstract available
Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic
Patients.
Ann Pharmacother. 2025 May 6:10600280251328530. doi: 10.1177/10600280251328530.
PubMed
Abstract available
Altered T-cell reactivity in the early stages of Alzheimer's disease.
Brain. 2025 May 5:awaf167. doi: 10.1093.
PubMed
Abstract available
Protection of dauricine and daurisoline on PC12 cells damaged by glutamate or
Abeta(25-35).
Brain Res. 2025;1857:149609.
PubMed
Abstract available
Age- and Genotype-Dependent Effects of Chronic Nicotine on Presenilin1/2 Double
Knockout Mice: From Behavior to Molecular Pathways.
Curr Alzheimer Res. 2024;21:817-832.
PubMed
Abstract available
Validity and Reliability of Outcome Measurement Instruments for Cognitive
Function in Alzheimer's Disease: A Systematic Review.
Dement Geriatr Cogn Disord. 2025 May 3:1-30. doi: 10.1159/000545907.
PubMed
Abstract available
Dietary inflammatory index and Alzheimer's disease mortality in a prospective
cohort.
Exp Gerontol. 2025;206:112770.
PubMed
Abstract available
The unsafe profile of lecanemab.
J Alzheimers Dis. 2025;105:62-64.
PubMed
Abstract available
A preliminary study on plasma markers across cognitive stages and links to a
history of mild traumatic brain injury.
J Alzheimers Dis. 2025;105:49-55.
PubMed
Abstract available
Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease
pathways: Modulation of amyloid-beta42 secretion, tau phosphorylation, phagocytosis,
and autophagy.
J Alzheimers Dis. 2025 May 4:13872877251339774. doi: 10.1177/13872877251339774.
PubMed
Abstract available
Modeling Alzheimer's disease: Bayesian copula graphical model from demographic,
cognitive, and neuroimaging data.
J Alzheimers Dis. 2025 May 4:13872877251337944. doi: 10.1177/13872877251337944.
PubMed
Abstract available
Chronic gingivitis increases the risk of early-onset Alzheimer's disease.
J Alzheimers Dis. 2025 May 4:13872877251336259. doi: 10.1177/13872877251336259.
PubMed
Abstract available
EPRCN exerts neuroprotective function by regulating gut microbiota and restoring
gut immune homeostasis in Alzheimer's disease model mice.
J Alzheimers Dis. 2025 May 5:13872877251339762. doi: 10.1177/13872877251339762.
PubMed
Abstract available
(18)F-FDG PET for the differential diagnosis of Alzheimer's disease and
frontotemporal lobar degeneration: A multicenter prospective study in Japan.
J Alzheimers Dis. 2025 May 5:13872877251338691. doi: 10.1177/13872877251338691.
PubMed
Abstract available
Correlations between agitation and other neuropsychiatric symptoms in each stage
of Alzheimer's disease: A re-analysis of CATIE-AD.
J Alzheimers Dis. 2025 May 5:13872877251340402. doi: 10.1177/13872877251340402.
PubMed
Abstract available
Immunocal((R)), a cysteine-rich whey protein, rescues reelin and reduces amyloid
plaque burden in a transgenic amyloid-beta protein precursor (hAbetaPP(SweInd)) mouse
model of Alzheimer's disease.
J Alzheimers Dis. 2025 May 5:13872877251338323. doi: 10.1177/13872877251338323.
PubMed
Abstract available
Angiogenesis promotion of the transplantation of human amniotic mesenchymal stem
cells via the Ang-1/Tie-2 signaling pathways in Alzheimer's disease model.
J Alzheimers Dis. 2025 May 5:13872877251338687. doi: 10.1177/13872877251338687.
PubMed
Abstract available
Obesity and Alzheimer's disease dementia: Examining inflammatory links to
cognitive decline and neuropsychiatric symptoms.
J Alzheimers Dis. 2025 May 6:13872877251338467. doi: 10.1177/13872877251338467.
PubMed
Abstract available
Trends and research focus on autophagy in Alzheimer's disease (2003-2023): A
bibliometric study.
J Alzheimers Dis. 2025 May 6:13872877251336442. doi: 10.1177/13872877251336442.
PubMed
Abstract available
Disruptive resting state networks characterizing depressive comorbidity in
Alzheimer's disease and mild cognitive impairment.
J Alzheimers Dis. 2025 May 6:13872877251337770. doi: 10.1177/13872877251337770.
PubMed
Abstract available
Identification of NDUFV2, NDUFS7, OPA1, and NDUFA1 as biomarkers for Alzheimer's
disease: Insights from oxidative stress and mitochondrial dysfunction in the
hippocampus.
J Alzheimers Dis. 2025 May 7:13872877251339771. doi: 10.1177/13872877251339771.
PubMed
Abstract available
Artificial intelligence-driven natural language processing for identifying
linguistic patterns in Alzheimer's disease and mild cognitive impairment: A study
of lexical, syntactic, and cohesive features of speech through picture
description tasks.
J Alzheimers Dis. 2025 May 7:13872877251339756. doi: 10.1177/13872877251339756.
PubMed
Abstract available
Blood biomarkers of amyloid and tau pathologies, brain degeneration,
inflammation, and oxidative stress in early- and late-onset Alzheimer's disease.
J Alzheimers Dis. 2025 May 8:13872877251340955. doi: 10.1177/13872877251340955.
PubMed
Abstract available
Differential effects of antidepressants on cognition in Alzheimer's disease with
depression: A sub-group analysis of an open-label, observational study.
J Alzheimers Dis. 2025 May 7:13872877251340084. doi: 10.1177/13872877251340084.
PubMed
Abstract available
Assessing the Content of Goals of Care Documentation for Hospitalized Patients
With Alzheimer's Disease and Related Dementias.
J Am Geriatr Soc. 2025 May 2. doi: 10.1111/jgs.19502.
PubMed
Abstract available
On the complexity of biomarker-driven diagnoses of Alzheimer's disease.
J Neuropsychol. 2025 May 2. doi: 10.1111/jnp.12428.
PubMed
Abstract available
Tooth loss, periodontal infection and their relationship to cognitive impairment
and other dementias: A review.
Neuro Endocrinol Lett. 2024;45.
PubMed
Abstract available
Brain microRNAs differentially expressed in age-related cerebral pathologies.
Neurobiol Aging. 2025;151:42-53.
PubMed
Abstract available
Higher soluble ADAM10 plasma levels are associated with decreased cognitive
performance in older adults carrying APOEepsilon4.
Neurobiol Aging. 2025;151:70-75.
PubMed
Abstract available
Calpain and caspase regulate Abeta peptide production via cleavage of KINDLIN2
encoded by the AD-associated gene FERMT2.
Neurobiol Aging. 2025;151:117-125.
PubMed
Abstract available
Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep:
Potential implications for therapeutic targets in Alzheimer's disease.
Neurobiol Aging. 2025;152:25-33.
PubMed
Abstract available
Identification of Novel Biomarkers Related to Vesicle Trafficking in Alzheimer's
Disease Using Bioinformatics Approaches.
Neurochem Res. 2025;50:157.
PubMed
Abstract available
Diabetes affects AD through plasma Abeta40: A Mendelian randomization study.
Neuroscience. 2025;575:131-139.
PubMed
Abstract available
Causal relationship between schizophrenia and five types of dementia: A
bidirectional two-sample Mendelian randomization study.
PLoS One. 2025;20:e0322752.
PubMed
Abstract available
Retraction: Structure-based virtual screening of Trachyspermum ammi metabolites
targeting acetylcholinesterase for Alzheimer's disease treatment.
PLoS One. 2025;20:e0324094.
PubMed
A systematic analysis for disease burden, risk factors, and trend projection of
Alzheimer's disease and other dementias in China and globally.
PLoS One. 2025;20:e0322574.
PubMed
Abstract available
Quantitative 3D histochemistry reveals region-specific amyloid-beta reduction by the
antidiabetic drug netoglitazone.
PLoS One. 2025;20:e0309489.
PubMed
Abstract available
Genetic variability in ADAM17/TACE is associated with sporadic Alzheimer's
disease risk, neuropsychiatric symptoms and cognitive performance on the Rey
Auditory Verbal Learning and Clock Drawing Tests.
PLoS One. 2025;20:e0309631.
PubMed
Abstract available
Protective potential of BM-MSC extracted Exosomes in a rat model of Alzheimer's
disease.
PLoS One. 2025;20:e0320883.
PubMed
Abstract available
The relationship between dementia staging scales, cognitive-behavioral scales and
functionality in patients with cognitive impairment.
PLoS One. 2025;20:e0322572.
PubMed
Abstract available
Thank you for your interest in scientific medicine.